Researchers reported that topical testosterone gel replacement reduced insulin resistance and glycated hemoglobin in men who were deficient in the hormone.
According to Hugh Jones MD of the University of Sheffield in England "This was the first large placebo-controlled study to show that testosterone replacement in hypogonadal men with metabolic syndrome or diabetes improves insulin resistance and glycemic control." Low testosterone is a known risk factor for type 2 diabetes in men. Up to one-third of men with type 2 diabetes are testosterone-deficient, due to aging or treatment for prostate or testicular cancer. Moreover, glycated hemoglobin levels were cut by half a percentage point after six months of treatment, Jones said during a presentation here at at the Society for Endocrinology annual meeting.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment